Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 554

1.

Circulating α-klotho levels in CKD and relationship to progression.

Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH.

Am J Kidney Dis. 2013 Jun;61(6):899-909. doi: 10.1053/j.ajkd.2013.01.024. Epub 2013 Mar 27.

PMID:
23540260
2.

Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis.

Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y.

Clin Exp Nephrol. 2012 Oct;16(5):722-9. doi: 10.1007/s10157-012-0621-7. Epub 2012 Mar 29.

PMID:
22457086
3.

Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.

Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.

Nephrol Dial Transplant. 2013 Feb;28(2):352-9. doi: 10.1093/ndt/gfs460. Epub 2012 Nov 4.

PMID:
23129826
4.

[Significance of the morphogenetic proteins FGF-23 and Klotho as predictors of prognosis of chronic kidney disease].

Milovanova LIu, Milovanov IuS, Kozlovskaia LV, Mukhin NA.

Ter Arkh. 2014;86(4):36-44. Russian.

PMID:
24864466
5.

[New markers of cardio-renal links in chronic kidney disease].

Milovanova LIu, Milovanov IuS, Kozlovskaia LV, Mukhin NA.

Ter Arkh. 2013;85(6):17-24. Russian.

PMID:
23866594
6.

FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy.

Lundberg S, Qureshi AR, Olivecrona S, Gunnarsson I, Jacobson SH, Larsson TE.

Clin J Am Soc Nephrol. 2012 May;7(5):727-34. doi: 10.2215/CJN.10331011. Epub 2012 Mar 1.

7.

In chronic kidney disease, serum α-Klotho is related to serum bicarbonate and proteinuria.

Hage V, Pelletier S, Dubourg L, Drai J, Cuerq C, Lemoine S, Hadj-Aissa A, Laville M, Fouque D.

J Ren Nutr. 2014 Nov;24(6):390-4. doi: 10.1053/j.jrn.2014.06.009. Epub 2014 Sep 3.

PMID:
25193108
8.

Soluble klotho and autosomal dominant polycystic kidney disease.

Pavik I, Jaeger P, Ebner L, Poster D, Krauer F, Kistler AD, Rentsch K, Andreisek G, Wagner CA, Devuyst O, Wüthrich RP, Schmid C, Serra AL.

Clin J Am Soc Nephrol. 2012 Feb;7(2):248-57. doi: 10.2215/CJN.09020911. Epub 2011 Dec 22.

9.

Characteristics of urinary and serum soluble Klotho protein in patients with different degrees of chronic kidney disease.

Akimoto T, Yoshizawa H, Watanabe Y, Numata A, Yamazaki T, Takeshima E, Iwazu K, Komada T, Otani N, Morishita Y, Ito C, Shiizaki K, Ando Y, Muto S, Kuro-o M, Kusano E.

BMC Nephrol. 2012 Nov 23;13:155. doi: 10.1186/1471-2369-13-155.

10.

Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.

Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.

Nephrol Dial Transplant. 2013 Jan;28(1):153-61. doi: 10.1093/ndt/gfs411. Epub 2012 Nov 23.

PMID:
23180879
11.

[Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].

Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA.

Ter Arkh. 2015;87(6):10-16. doi: 10.17116/terarkh201587610-16. Russian.

PMID:
26281189
12.

Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A.

Kacso IM, Bondor CI, Kacso G.

Clin Biochem. 2012 Nov;45(16-17):1415-20. doi: 10.1016/j.clinbiochem.2012.07.098. Epub 2012 Jul 23.

PMID:
22836100
13.

Soluble α-klotho and its relation to kidney function and fibroblast growth factor-23.

Scholze A, Liu Y, Pedersen L, Xia S, Roth HJ, Hocher B, Rasmussen LM, Tepel M.

J Clin Endocrinol Metab. 2014 May;99(5):E855-61. doi: 10.1210/jc.2013-4171. Epub 2014 Feb 25.

PMID:
24606097
14.

Serum bicarbonate and long-term outcomes in CKD.

Menon V, Tighiouart H, Vaughn NS, Beck GJ, Kusek JW, Collins AJ, Greene T, Sarnak MJ.

Am J Kidney Dis. 2010 Nov;56(5):907-14. doi: 10.1053/j.ajkd.2010.03.023. Epub 2010 Jun 3.

PMID:
20605301
15.

Combined use of vitamin D status and FGF23 for risk stratification of renal outcome.

Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Okada N, Tsubakihara Y, Isaka Y, Rakugi H.

Clin J Am Soc Nephrol. 2012 May;7(5):810-9. doi: 10.2215/CJN.08680811. Epub 2012 Feb 23.

16.

FGF-23 as a predictor of renal outcome in diabetic nephropathy.

Titan SM, Zatz R, Graciolli FG, dos Reis LM, Barros RT, Jorgetti V, Moysés RM.

Clin J Am Soc Nephrol. 2011 Feb;6(2):241-7. doi: 10.2215/CJN.04250510. Epub 2010 Oct 21.

17.

Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.

Ozeki M, Fujita S, Kizawa S, Morita H, Sohmiya K, Hoshiga M, Ishizaka N.

BMC Nephrol. 2014 Sep 8;15:147. doi: 10.1186/1471-2369-15-147.

18.

Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.

Perkins RM, Kirchner HL, Hartle JE, Bucaloiu ID.

Clin Nephrol. 2013 Oct;80(4):256-62. doi: 10.5414/CN107905.

PMID:
23993165
19.

[MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].

Milovanova LY, Kozlovskaya LV, Markina MM, Milovanova SY, Borisov AA, Mukhin NA, Fomin VV, Moiseev SV.

Klin Med (Mosk). 2015;93(12):32-8. Russian.

PMID:
27149811
20.

Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.

Fliser D, Kollerits B, Neyer U, Ankerst DP, Lhotta K, Lingenhel A, Ritz E, Kronenberg F; MMKD Study Group, Kuen E, König P, Kraatz G, Mann JF, Müller GA, Köhler H, Riegler P.

J Am Soc Nephrol. 2007 Sep;18(9):2600-8. Epub 2007 Jul 26.

Supplemental Content

Support Center